AML

Beijing, China, November 8, 2026 InnoCare Pharma has announced that the first patient has been dosed in its registrational...

New York, New York — October 30, 2026 Syndax Pharmaceuticals, Inc. announced that Revuforj® (revumenib) has received the 2026...

HOUSTON — September 28, 2026 Moleculin Biotech, Inc. announced publication of a peer-reviewed pooled analysis of the cardiac safety...

TÜBINGEN, Germany — September 23, 2026 ViferaXS GmbH announced the close of a Series A financing round of up...

LONDON — September 21, 2026 PureTech Health announced the successful completion of an End-of-Phase 1 meeting with the U.S....

BALLERUP, DENMARK, August 18, 2026 LEO Pharma has entered into an agreement to acquire worldwide rights to dersimelagon from...

LONDON, August 18, 2026 Smith+Nephew and Imperial College London have launched a new five-year partnership to accelerate innovation in...

BEIJING, August 18, 2026 InnoCare Pharma announced that China’s Center for Drug Evaluation (CDE) of the National Medical Products...

New York, United States, August 14, 2026 BrainStorm Cell Therapeutics Inc. announced its financial results for the second quarter...

Tokyo, Japan, August 16, 2026 Kyowa Kirin Co., Ltd. has selected Cognizant and Benchling as partners to implement an...